<DOC>
	<DOCNO>NCT02356341</DOCNO>
	<brief_summary>This observational study intend collect outcome data cohort 90 patient suffer symptom dry eye disease due meibomian gland dysfunction treat medical device NovaTears® eye drop duration 6 8 week .</brief_summary>
	<brief_title>NovaTears® Eye Drops Observational Study NT-002</brief_title>
	<detailed_description />
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>According NovaTears® instruction use ≥ 18 year Patients dry eye disease due meibomian gland dysfunction apply eye lid hygiene least 14 day Ability willingness provide write Informed Consent Ability willingness participate examination Willingness ability return follow visit Patients hypersensitivity component NovaTears® Patients contact lenses , pregnancy , breast feeding Patients dry eye disease cause meibomian gland dysfunction Patients take lipid contain eye drop require topical pharmacological treatment dry eye disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>